Neil Dahiya

ICICI Prudential Life Insurance recently unveiled ICICI Pru Wish, a groundbreaking health insurance product focused on women-specific serious ailments and surgeries. Created in collaboration with the Reinsurance Group of America (RGA), this insurance scheme targets the distinct health issues faced

DigiNerve, an innovative educational technology initiative by Jaypee Brothers Medical Publishers, is setting a new standard in orthopaedic medical instruction through the launch of its all-encompassing MS orthopaedics program. This course, crafted under the mentorship of top orthopaedic surgeons and

Introduction to Lasix ONYU’s Tentative Approval Gerresheimer, a pioneering provider of systems and solutions across pharmaceutical, biotech, and cosmetic sectors, announces the US Food and Drug Administration’s (FDA) provisional approval of SQ Innovation’s Lasix ONYU. This combination product, designed for

GSK plc has revealed that the European Medicines Agency (EMA) has awarded Priority Medicines (PRIME) status to GSK5764227 (GSK’227), a B7-H3-aimed antibody-drug conjugate (ADC) undergoing trials for patients with recurrent extensive-stage small-cell lung cancer (ES-SCLC). The PRIME Designation facilitates the

Innovent Biologics, a prominent biopharmaceutical company, and Eli Lilly and Company have jointly announced a Distribution and Promotion Agreement focused on introducing Lilly’s reversible BTK inhibitor, Jaypirca, to Mainland China. This partnership entails Innovent taking charge of importing, marketing, distributing,

Bavarian Nordic A/S, a worldwide leader in vaccine innovation aimed at improving health and saving lives, has struck a licensing and production deal with Serum Institute of India Pvt. Ltd. (SII) to manufacture its MVA-BN mpox vaccine. This collaboration involves

GSK plc has disclosed that the United States Food and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to Jemperli (dostarlimab) for patients dealing with locally advanced mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) rectal cancer. The Breakthrough Therapy

In a pivotal move, the Karnataka government has announced the consolidation of the Food Safety and Standards Department with the Drug Control Department, establishing the new entity named the Food Safety and Drug Administration (FDA), effective immediately. The newly formed